P/E ratio for Biolase (BIOL)
P/E ratio as of April 2024 (TTM): -0.0006
According to Biolase 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.000560525. At the end of 2022 the company had a P/E ratio of -0.0016.
P/E ratio history for Biolase from 2001 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | -0.0016 | -95.66% |
| 2021 | -0.0365 | 412.05% |
| 2020 | -0.0071 | 2.25% |
| 2019 | -0.0070 | -26.16% |
| 2018 | -0.0094 | -37.73% |
| 2017 | -0.0151 | -70.56% |
| 2016 | -0.0514 | 95.4% |
| 2015 | -0.0263 | -56.79% |
| 2014 | -0.0609 | -31.03% |
| 2013 | -0.0883 | -54.81% |
| 2012 | -0.1954 | 18.55% |
| 2011 | -0.1648 | 334.11% |
| 2010 | -0.0380 | -79.53% |
| 2009 | -0.1855 | 342.83% |
| 2008 | -0.0419 | -48.49% |
| 2007 | -0.0813 | -82.6% |
| 2006 | -0.4675 | 321.62% |
| 2005 | -0.1109 | -5.49% |
| 2004 | -0.1173 | -160.19% |
| 2003 | 0.1949 | -83.39% |
| 2002 | 1.17 | -235.08% |
| 2001 | -0.8685 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Align Technology
ALGN | 63.7 | -11,365,908.84% | 🇺🇸 USA |
 Dentsply Sirona
XRAY | -30.4 | 5,430,523.08% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.